[1]
Sagratzki , R.M.G., Silva, S.S. da, Mascarenhas , A.R.R., Póvoa , C.S., Souza , E.M., Silva , J.T.D., Santos , P.H.Q.D., Silva , V.B.M. and Paiva , M.J.M. de 2023. THE RISK OF POISONING FROM THE USE OF OZEMPIC (SEMAGLUTIDE) IN NON-DIABETIC PATIENTS. Brazilian Journal of Implantology and Health Sciences . 5, 4 (Sep. 2023), 1826–1837. DOI:https://doi.org/10.36557/2674-8169.2023v5n4p1826-1837.